Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
Mulder
L C
LC
Istituto Ricerche Immunobiologiche, Siena, Italy.
Mora
M
M
Lazzeri
M
M
Boschi
M
M
Ciccopiedi
E
E
Marinucci
G
G
Melli
C M
CM
Bruzzone
P
P
Alfani
D
D
Cortesini
R
R
Rossini
M
M
D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis* / Q000235:genetics; D016913:Blood Component Transfusion / Q000009:adverse effects; D018958:CD55 Antigens / Q000096:biosynthesis* / Q000235:genetics; D003169:Complement Inactivator Proteins / Q000096:biosynthesis*; D003165:Complement System Proteins / Q000032:analysis / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000473:pathology*; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D010477:Perfusion; D014183:Transplantation, Heterologous / Q000009:adverse effects
D015703:Antigens, CD; C497857:CD46 protein, human; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; C497859:Mcp protein, mouse; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D003165:Complement System Proteins